Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

NCT00802867 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

989

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Polio
Haemophilus Infection

Interventions

BIOLOGICAL: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)

Sponsor

Sanofi Pasteur, a Sanofi Company